Participant requirements

WAMHS participants were Western Australian adults, aged between 18 and 80 years, who were diagnosed with an invasive melanoma of the skin between January 2006 and September 2009.

For eligible patients to be contacted about the study, it was a requirement that their doctor had deemed them suitable for contact (actively or passively). 

All participants were recruited via the Western Australian Cancer Registry.

Data Collections

  • Study questionnaire

The full-launch questionnaire was administered by telephone interview and aimed to identify environmental and host risk factors. An overview of the themes addressed in both the pilot and full-launch study can be downloaded from the link below.

WAMHS Questionnaire Themes 

  • Blood samples

Blood samples were collected from consenting participants for the extraction of DNA, RNA and serum.

DNA samples will enable researchers to look at potential genes involved in melanoma.

RNA samples will be used in gene expression studies, to allow researchers to look at the proteins expressed by potential genes involved in melanoma.

Serum samples will be used for biochemical analyses.

  • Scar outcome sub-study

In collaboration with the McComb Foundation, the WAMHS also investigate host, environmental and genetic factors affecting scar outcome following melanoma excision.

Data for this part of the study was collected from pathology reports, questionnaires and clinical scar examinations. Details of each component can be downloaded from the link below.

Overview of Scar Outcome Substudy Data Collections